glp 1 agonists adverse effects The promise and peril of GLP-1 agonists: What we do (and don't) know as of August 2024 What are the side effects
Description
75 Although animal studies suggest the potential use of DPP4 inhibitors for SSc treatment, further clinical trials are needed to explore their effects on SSc patients
Gastric inhibitory polypeptide (GIP) dosedependently stimulates glucagon secretion in healthy human subjects at euglycaemia
Chantry, A., Leighton, B
The antidepressant effects of GLP-1 receptor agonists: A systematic review and Meta-Analysis
